CVRx Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Kevin Hykes

Chief Executive Officer (CEO)

US$245.8k

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	n/a
Permanencia media de la dirección	2.8yrs
Promedio de permanencia en la Junta Directiva	3.8yrs

Actualizaciones recientes de la dirección

Recent updates

Earnings Release: Here's Why Analysts Cut Their CVRx, Inc. (NASDAQ:CVRX) Price Target To US$20.33

Feb 18

CVRx: The Path To 7x Investment Returns

Jan 07

CVRx: High Risk And High Potential Reward

Jul 04

CEO

Kevin Hykes (57 yo)

less than a year

Permanencia

US$245,843

Compensación

Mr. Kevin Hykes serves as Director of CVRx, Inc. since December 21, 2022 and serves as President and Chief Executive Officer since February 12, 2024. He serves as President, Director & Chief Executive Offi...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kevin Hykes	President	less than a year	US$245.84k	sin datos
Jared Oasheim	Chief Financial Officer	3.5yrs	US$822.79k	0.072% $ 230.2k
Paul Verrastro	Chief Marketing & Strategy Officer	3.3yrs	US$833.11k	0.0037% $ 12.0k
Paul Pignato	Vice President of Operations	2.3yrs	sin datos	sin datos
Jonelle Burnham	Vice President & General Counsel	1.1yrs	sin datos	sin datos
Craig Palmer	Senior Vice President of US Sales	12.3yrs	sin datos	0.0057% $ 18.3k

2.8yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: CVRXEl equipo directivo de la empresa se considera experimentado (3 años de antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kevin Hykes	President	1.3yrs	US$245.84k	sin datos
Joseph Slattery	Independent Director	15.5yrs	US$167.45k	0.10% $ 329.9k
Ali Behbahani	Independent Director	10.8yrs	US$159.95k	0.0015% $ 4.7k
Kirk Nielsen	Independent Director	3.8yrs	US$154.95k	0% $ 0
Mudit Jain	Independent Director	3.8yrs	US$157.45k	0.016% $ 50.6k
Martha Shadan	Independent Director	2.8yrs	US$147.20k	0% $ 0

3.8yrs

Permanencia media

57yo

Promedio de edad

Junta con experiencia: La junta directiva de CVRX se considera experimentada (3.4 años de antigüedad promedio).

CVRx Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Chief Marketing & Strategy Officer notifies of intention to sell stock

CVRx, Inc. Announces Chief Executive Officer Changes, Effective February 12, 2024

CVRx, Inc. Announces Appointment of Kevin Hykes as President, Effective February 12, 2024

CVRx, Inc. Announces Appointment of Kevin Hykes as President, Effective February 12

CVRx, Inc. Announces Nadim Yared Retires as Chief Executive Officer

CVRx, Inc. Announces Nadim Yare Retires as President

Recent updates

CVRx, Inc. to Report Q1, 2024 Results on Apr 30, 2024

New minor risk - Shareholder dilution

Rock star Growth Puts CVRx (NASDAQ:CVRX) In A Position To Use Debt

The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 25%

Chief Marketing & Strategy Officer notifies of intention to sell stock

CVRx, Inc. Announces Chief Executive Officer Changes, Effective February 12, 2024

CVRx, Inc. Announces Appointment of Kevin Hykes as President, Effective February 12, 2024

CVRx, Inc. Announces Appointment of Kevin Hykes as President, Effective February 12

Full year 2023 earnings: EPS exceeds analyst expectations

CVRx, Inc. to Report Q4, 2023 Results on Jan 25, 2024

CVRx, Inc. Announces Nadim Yared Retires as Chief Executive Officer

CVRx, Inc. Announces Nadim Yare Retires as President

CVRx, Inc. Receives FDA Approval for Expanded Labing of Barostim

Price target increased by 16% to US$23.60

Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 34%

New minor risk - Share price stability

CVRx, Inc. Provides Revenue Guidance for the Fourth Quarter 2023

Price target decreased by 9.3% to US$19.40

CVRx, Inc. to Report Q3, 2023 Results on Oct 26, 2023

New major risk - Revenue and earnings growth

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

CVRx, Inc. Revises Financial Guidance for the Full Year 2023

CVRx, Inc. to Report Q2, 2023 Results on Jul 25, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Full year 2022 earnings: EPS and revenues exceed analyst expectations

CVRx, Inc. to Report Q4, 2022 Results on Jan 26, 2023

CVRx, Inc. Provides Preliminary Unaudited Revenue Guidance for the Fourth Quarter and Full Year of 2022 and Provides Revenue Guidance for the First Quarter and Full Year of 2023

CVRx, Inc. Appoints Kevin Hykes to Board of Directors

Price target increased to US$17.25

Chief Marketing & Strategy Officer notifies of intention to sell stock

Price target increased to US$14.75

CVRx, Inc. Launches New Barostim NEO2(TM) Implantable Pulse Generator

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

CVRx, Inc. announced that it expects to receive $65 million in funding from Innovatus Capital Partners, LLC

CVRx, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Companies Like CVRx (NASDAQ:CVRX) Are In A Position To Invest In Growth

CVRx Pursues Revenue Growth But Operating Losses Worsen

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

CVRx, Inc. Revises Earnings Guidance for the Full Year of 2022

CVRx, Inc. to Report Q2, 2022 Results on Jul 28, 2022

CVRx, Inc. Launches A New Barostim Programmer

CVRx, Inc.(NasdaqGS:CVRX) dropped from Russell 2500 Value Index

CVRx: Barostim Story Looks Well Priced In, Overvalued At Just 5x Sales

CVRx, Inc. Receives U.S. Food and Drug Administration Approval for Magnetic Resonance Conditional Labeling for Its Barostim System

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

CVRx, Inc., Annual General Meeting, Jun 07, 2022

CVRx, Inc. to Report Q1, 2022 Results on Apr 25, 2022

We Think CVRx (NASDAQ:CVRX) Can Afford To Drive Business Growth

Consensus forecasts updated

Earnings Release: Here's Why Analysts Cut Their CVRx, Inc. (NASDAQ:CVRX) Price Target To US$20.33

Full year 2021 earnings: EPS exceeds analyst expectations

CVRx, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2022

CVRx, Inc. to Report Q4, 2021 Results on Feb 15, 2022

Cvrx, Inc. Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year of 2021 and First Quarter and Full Year of 2022

CVRx: The Path To 7x Investment Returns

Third quarter 2021 earnings released: US$0.30 loss per share

CVRx, Inc. Provides Earnings Guidance for the Third Quarter of 2021; Provides Earnings Guidance for the Year 2021

CVRx: High Risk And High Potential Reward

CVRx, Inc. has completed an IPO in the amount of $126 million.

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad